While l-glyceraldehyde shows promise in inhibiting tumor growth, d-glyceraldehyde offers potential benefits in inducing insulin production, presenting a novel therapeutic avenue for diabetes management (Fig. 2). This evidence concerns the gene INS and neoplasm.